Prof. Elena Verdu - Speaker at Microbiota events
Microbiotaevents chevron Speakers chevron Elena Verdu

Prof. Elena Verdu

MD, PhD, Professor division of gastroenterology, Dept of medicine, McMaster University (Ontario, Canada)

Prof. Elena Verdu is a Professor at Mc Master University, Division of Gastroenterology, and a Canada Research Chair in Inflammation, Microbiota and Nutrition. She is Associate Director of the Farncombe Family Digestive Health Research Institute. The purpose of this Institute is to better understand, treat, and ultimately cure, the most common categories of intestinal illness that burden our society: inflammatory, functional and diet-induced disorders. She is also Director of Axenic Gnotobiotic Unit of the McMaster University. 

  • Faculty of Health Sciences, McMaster University
  • Associate Director, Farncombe Family Digestive Health Research Institute, Faculty of Health Sciences
  • Canada Research Chair in Inflammation, Microbiota and Nutrition, McMaster University
  • Director, Axenic Gnotobiotic, Mc Master University

Prof. Elena Verdu is a Professor at Mc Master University, Division of Gastroenterology, and a Canada Research Chair in Inflammation, Microbiota and Nutrition. She is Associate Director of the Farncombe Family Digestive Health Research Institute. The purpose of this Institute is to better understand, treat, and ultimately cure, the most common categories of intestinal illness that burden our society: inflammatory, functional and diet-induced disorders. She is also Director of Axenic Gnotobiotic Unit of the McMaster University. 

  • Faculty of Health Sciences, McMaster University
  • Associate Director, Farncombe Family Digestive Health Research Institute, Faculty of Health Sciences
  • Canada Research Chair in Inflammation, Microbiota and Nutrition, McMaster University
  • Director, Axenic Gnotobiotic, Mc Master University
Why you should listen

Prof. Verdu has had a longstanding interest in microbial commensal influence on chronic inflammatory diseases. After completing an MD degree and Internal Medicine residency at the University of Buenos Aires, Argentina, she trained in clinical research in Gastroenterology, focused on Helicobacter pylori infection and chronic gastritis at the University of Lausanne, Switzerland. She studied the interaction between chronic infection with Helicobacter pylori and proton pump inhibitors on acid secretion, bacterial overgrowth, and chronic gastritis in humans.

 

She earned a doctoral degree in Human Physiology for her thesis on the interaction between chronic H. pylori infection and inhibition of gastric acid secretion, under the direction of Prof. André Blum. She then undertook PhD studies at the Institute of Microbiology and Gnotobiology of the Czech Academy of Science in Prague, where she investigated the effect of commensal bacterial antigens in animal models of inflammatory bowel disease and celiac disease.

 

As a post-doctoral fellow at McMaster University, she worked on the role of probiotic in animal models of gut functional diseases, and in 2006, she became faculty at McMaster University. Her research program investigates host-microbial and dietary interactions in the gastrointestinal tract. In particular, she is interested in the role microbial factors play in modulating immune responses in chronic intestinal conditions such as inflammatory bowel disease and celiac disease. Mechanistically, she focusses on commensal and opportunistic pathogen metabolism and proteolytic activity, with the long-term objective to develop therapies to prevent or treat chronic inflammatory and autoimmune conditions.

She holds a Canadian Research Chair in Intestinal Inflammation, Microbiota, and Nutrition, and directs the Axenic Gnotobiotic Unit at McMaster University. She is the Associate Director of the Farncombe Family Digestive Health Research Institute at McMaster University.

 

She has been honored by the 2007 New Investigator Award (Canadian Celiac Association; CCA), the 2011 Master’s Award in Gastroenterology in Basic Science (American Gastroenterology Association), the 2012 Canadian Association of Gastroenterology (CAG) Young Investigator Award, the 2017 CAG Visiting Research Professor Award, the 2019 CAG Education Excellence Award, the 2020 CAG Research Excellence Award, and the 2020 Crohn’s and Colitis of Canada (CCC)-Pfizer Women in IBD: Outstanding Research Achievement Award.

Key Studies

Galipeau J-H. et al.
Novel Fecal Biomarkers That Precede Clinical Diagnosis of Ulcerative Colitis.
Gastroenterology. 2021 Apr;160(5):1532-1545.
https://pubmed.ncbi.nlm.nih.gov/33310084/

Constante M. et al.
Saccharomyces boulardii CNCM I-745 modulates the microbiota-gut-brain axis in a humanized mouse model of Irritable Bowel Syndrome.
Neurogastroenterol Motil. 2021 Mar;33(3):e13985
https://pubmed.ncbi.nlm.nih.gov/32955166/

Lamas B. et al.
Aryl hydrocarbon receptor ligand production by the gut microbiota is decreased in celiac disease leading to intestinal inflammation.
Sci Transl Med. 2020 Oct 21;12(566):eaba0624.
https://pubmed.ncbi.nlm.nih.gov/33087499/

 

Pinto-Sanchez M-I. et al.
Association Between Inflammatory Bowel Diseases and Celiac Disease: A Systematic Review and Meta-Analysis.
Gastroenterology. 2020 Sep;159(3):884-903.e31
https://pubmed.ncbi.nlm.nih.gov/32416141/

 

Motta J-P. et al.
Active thrombin produced by the intestinal epithelium controls mucosal biofilms.
Nat Commun. 2019 Jul 19;10(1):3224.
https://pubmed.ncbi.nlm.nih.gov/31324782/

 

Caminero A. et al.
Lactobacilli Degrade Wheat Amylase Trypsin Inhibitors to Reduce Intestinal Dysfunction Induced by Immunogenic Wheat Proteins.
Gastroenterology. 2019 Jun;156(8):2266-2280.
https://pubmed.ncbi.nlm.nih.gov/30802444/

 

Lindfors K. et al.
Coeliac disease.
Nat Rev Dis Primers. 2019 Jan 10;5(1):3.
https://pubmed.ncbi.nlm.nih.gov/30631077/

 

Libertucci J. et al.
Inflammation-related differences in mucosa-associated microbiota and intestinal barrier function in colonic Crohn's disease.
Am J Physiol Gastrointest Liver Physiol. 2018 Sep 1;315(3):G420-G431.
https://pubmed.ncbi.nlm.nih.gov/29848021/

 

Meisel M. et al.
Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host.
Nature. 2018 May;557(7706):580-584
https://pubmed.ncbi.nlm.nih.gov/29769727/

 

 

Thevaranjan N. et al.
Age-Associated Microbial Dysbiosis Promotes Intestinal Permeability, Systemic Inflammation, and Macrophage Dysfunction.
Cell Host Microbe. 2017 Apr 12;21(4):455-466.e4.
https://pubmed.ncbi.nlm.nih.gov/28407483/

 

Caminero A. et al.
Duodenal Bacteria From Patients With Celiac Disease and Healthy Subjects Distinctly Affect Gluten Breakdown and Immunogenicity.
Gastroenterology. 2016 Oct;151(4):670-83.
https://pubmed.ncbi.nlm.nih.gov/27373514/

Prof. Elena Verdu’s Microbiota Events

Wednesday, 18th May 2022
4:00pm - 4:35pm (CET)

The impact of antibiotics in the microbiota ecosystem.